ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Genetic association of lipid-lowering drugs with aortic aneurysms: a Mendelian randomization study

Gao, Xiong; Luo, Wei; Qu, Liyuan; Yang, Miaomiao; Chen, Siyu; Lei, Li; Yan, Shaohua; Liang, Hongbin; Zhang, Xinlu; Xiao, Min; Liao, Yulin; Lee, Alex Pui-Wai; Zhou, Zhongjiang; Chen, Jiejian; Zhang, Qiuxia*; Wang, Yuegang*; Xiu, Jiancheng*南方医科大学; 1
European Journal of Preventive Cardiology2024-2-1DOI: 10.1093/eurjpc/zwae044
6阅读
引用收藏
分享

摘要

Aims The lack of effective pharmacotherapies for aortic aneurysms (AA) is a persistent clinical challenge. Lipid metabolism plays an essential role in AA. However, the impact of lipid-lowering drugs on AA remains controversial. The study aimed to investigate the genetic association between lipid-lowering drugs and AA.Methods and results Our research used publicly available data on genome-wide association studies (GWASs) and expression quantitative trait loci (eQTL) studies. Genetic instruments, specifically eQTLs related to drug-target genes and SNPs (single nucleotide polymorphisms) located near or within the drug-target loci associated with low-density lipoprotein cholesterol (LDL-C), have been served as proxies for lipid-lowering medications. Drug-Target Mendelian Randomization (MR) study is used to determine the causal association between lipid-lowering drugs and different types of AA. The MR analysis revealed that higher expression of HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) was associated with increased risk of AA (OR = 1.58, 95% CI = 1.20-2.09, P = 1.20 x 10-03) and larger lumen size (aortic maximum area: OR = 1.28, 95% CI = 1.13-1.46, P = 1.48 x 10-04; aortic minimum area: OR = 1.26, 95% CI = 1.21-1.42, P = 1.78 x 10-04). PCSK9 (proprotein convertase subtilisin/kexin type 9) and CETP (cholesteryl ester transfer protein) show a suggestive relationship with AA (PCSK9: OR = 1.34, 95% CI = 1.10-1.63, P = 3.07 x 10-03; CETP: OR = 1.38, 95% CI = 1.06-1.80, P = 1.47 x 10-02). No evidence to support genetically mediated NPC1L1 (Niemann-Pick C1-Like 1) and LDLR (low-density lipoprotein cholesterol receptor) are associated with AA.Conclusion This study provides causal evidence for the genetic association between lipid-lowering drugs and AA. Higher gene expression of HMGCR, PCSK9, and CETP increases AA risk. Furthermore, HMGCR inhibitors may link with smaller aortic lumen size.Lay summary This Mendelian randomization study used publicly available data involving over 1 million individuals to demonstrate the causal relationship between five target genes of LDL-C-lowering medicines and the risk of aortic aneurysms, and implied one lipid-lowering drug may link with the lumen size of aortic aneurysms. @@@ Graphical Abstract

学科与关键词

关键词
Aortic aneurysmsLipid-lowering drugsMendelian randomizationGenetic instrumentsCausal relationship
相关
加载中…
  • The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis
    Wang, Shiyue; Zha, Li; Chen, Jian; Du, Dongjie; Liu, Danyang; Zhong, Ming; Shang, Rongfang; Sun, Dongxue; Sun, Chang; Jin, Enze*EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27(1): 211.被引 7
  • Association between the use of lipid-lowering drugs and the risk of inflammatory bowel disease
    Liu, Xuxu; Lv, Zhenyi; Xie, Zhihong; Wang, Qiang; Yao, Wenchao; Yu, Jingjing; Jing, Qingxu; Meng, Xianzhi; Ma, Biao; Xue, Dongbo*; Hao, Chenjun*European Journal of Clinical Investigation, 2023, 53(12): e14067.被引 1
  • A systematic review of LDLR, PCSK9, and APOB variants in Asia
    Nejat, Mahdieh; Katayoun, Heshmatzad; Bahareh, RabbaniAtherosclerosis, 2020, 305: 50-57.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Preventive Cardiology
发表日期
2024-02-01
DOI
10.1093/eurjpc/zwae044
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R&D Program of China; GTEx Consortium

作者

  • G

    Gao, Xiong (第一作者)

    southern med univ

  • L

    Luo, Wei

    southern med univ

查看全部 17 位作者收起作者
  • Q

    Qu, Liyuan

    1 · 2

  • Y

    Yang, Miaomiao

    southern med univ

  • C

    Chen, Siyu

    southern med univ

  • L

    Lei, Li

  • Y

    Yan, Shaohua

    southern med univ

  • L

    Liang, Hongbin

    southern med univ

  • Z

    Zhang, Xinlu

    southern med univ

  • X

    Xiao, Min

    southern med univ

  • L

    Liao, Yulin

    southern med univ

  • L

    Lee, Alex Pui-Wai

    chinese univ hong kong

  • Z

    Zhou, Zhongjiang

    southern med univ

  • C

    Chen, Jiejian

    1

  • Z

    Zhang, Qiuxia (通讯)

    southern med univ

  • W

    Wang, Yuegang (通讯)

    southern med univ

  • X

    Xiu, Jiancheng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417